2 false false false false false false false false false true false false false false false false No description of principal activity 2022-09-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 12831899 2022-09-01 2023-08-31 12831899 2023-08-31 12831899 2021-09-01 2022-08-31 12831899 2022-08-31 12831899 bus:OrdinaryShareClass1 2022-09-01 2023-08-31 12831899 bus:Director1 2022-09-01 2023-08-31 12831899 core:WithinOneYear 2023-08-31 12831899 core:WithinOneYear 2022-08-31 12831899 core:ShareCapital 2023-08-31 12831899 core:ShareCapital 2022-08-31 12831899 core:RetainedEarningsAccumulatedLosses 2023-08-31 12831899 core:RetainedEarningsAccumulatedLosses 2022-08-31 12831899 bus:SmallEntities 2022-09-01 2023-08-31 12831899 bus:AuditExemptWithAccountantsReport 2022-09-01 2023-08-31 12831899 bus:FullAccounts 2022-09-01 2023-08-31 12831899 bus:SmallCompaniesRegimeForAccounts 2022-09-01 2023-08-31 12831899 bus:PrivateLimitedCompanyLtd 2022-09-01 2023-08-31 12831899 bus:OrdinaryShareClass1 2023-08-31 12831899 bus:OrdinaryShareClass1 2022-08-31
COMPANY REGISTRATION NUMBER: 12831899
MM MED LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
31 August 2023
MM MED LIMITED
FINANCIAL STATEMENTS
YEAR ENDED 31 AUGUST 2023
Contents
Pages
Balance sheet 1
Notes to the financial statements 2 to 3
MM MED LIMITED
BALANCE SHEET
31 August 2023
2023
2022
Note
£
£
Current assets
Debtors
5
2,460
Cash at bank and in hand
53,752
28,991
------------
------------
56,212
28,991
Creditors: amounts falling due within one year
6
( 8,979)
( 6,239)
------------
------------
Net current assets
47,233
22,752
------------
------------
Total assets less current liabilities
47,233
22,752
------------
------------
Net assets
47,233
22,752
------------
------------
Capital and reserves
Called up share capital
7
100
100
Profit and loss account
47,133
22,652
------------
------------
Shareholders funds
47,233
22,752
------------
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the profit and loss account has not been delivered.
For the year ending 31 August 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 1 February 2024 , and are signed on behalf of the board by:
Dr M A Swingler
Director
Company registration number: 12831899
MM MED LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 AUGUST 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 35 Westgate, Huddersfield, West Yorkshire, HD1 1PA.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
5. Debtors
2023
2022
£
£
Trade debtors
2,460
------------
------------
6. Creditors: amounts falling due within one year
2023
2022
£
£
Accruals and deferred income
1,506
900
Corporation tax
6,681
4,411
Social security and other taxes
303
303
Director loan accounts
489
537
Other creditors
88
------------
------------
8,979
6,239
------------
------------
7. Called up share capital
Issued, called up and fully paid
2023
2022
No.
£
No.
£
Ordinary shares of £ 1 each
100
100
100
100
------------
------------
------------
------------
8. Related party transactions
The director's loan of £489 (2022: £537) as set out above is unsecured, repayable on demand and currently interest free.
9. Controlling party
The company is controlled by the directors.